Navigation Links
Origin BioMed Awarded Red Herring Top 100 Global Company
Date:1/27/2009

Halifax-based consumer health products company recognized as a world technology leader

HALIFAX, Nova Scotia, Jan. 27 /PRNewswire/ -- Origin BioMed Inc., a privately-held Canadian consumer health products company, today announced that it has been awarded as one of the Red Herring Top 100 Global Companies.

Red Herring Top 100 Global Companies are chosen from winners and finalists of the previous competitions for North America, Europe and Asia Red Herring Top 100 Companies. Out of 1,800 successful and highly eligible companies, the Red Herring editorial team deployed a detailed process to drill-down the best companies first to 200 finalists, then to the top 100 winners of this global award. Evaluations were made on both quantitative and qualitative criteria, such as financial performance, innovation, management, global strategy, and ecosystem integration.

The announcement of the winners was made at the Red Herring 100 Global taking place in San Diego from January 14-16, 2009. Present among the finalists were elite executives and venture capital leaders from around the world.

"We were so pleased to announce Origin BioMed Inc. as a Red Herring Top 100 Global Company," commented Red Herring publisher Alex Vieux. "Origin BioMed has proven to be a company excelling in their industry and its ripples have turned into waves. It was difficult for us to narrow down, but we are pleased to have included Origin BioMed in our list of promising companies. We look forward to the changes it makes to the non-prescription drug industry in the future." Origin was one of only 4 Canadian companies to receive the Award, with companies from 25 other countries also receiving the award.

"Since its inception, Origin's mission has been to leverage cutting edge technology to bring scientifically proven natural products to professional care givers and consumers. We strive to increase over-the-counter treatment options for nerve pain, and Red Herring's recognition demonstrates that our model has begun to position us as a global leader in our field," said Robert Cervelli, President and CEO, Origin BioMed. "It was a real honour to accept this award on behalf of the entire dynamic team at Origin," he added.

Origin BioMed's leading drug product, Neuragen(R), is the first non-prescription topical treatment for rapid relief of diabetic and post-shingles nerve pain. Neuragen(R) is available in all leading pharmacies in Canada and the United States.

About Origin BioMed Inc.

Origin BioMed, Inc. is a privately-held Canadian consumer health products company with business operations throughout the U.S. and Canada. Headquartered in Halifax, Nova Scotia, Origin BioMed Inc. manufactures health products with the highest quality active ingredients, at therapeutic levels, with evidence of scientific or clinical efficacy since 2001. Its leading drug product, Neuragen(R), helps relieve pain caused by diabetic nerve damage. For more information, please visit: www.originbiomed.com or www.neuragen.com.

    Contact:
    Robert Silverstein
    VP Operations
    902-444-8696
    silverstein@originbiomed.com

About Red Herring

Red Herring is a global media company, which unites the world's best high technology innovators, venture investors and business decision makers in a variety of forums: a leading innovation magazine, an online daily technology news service, technology newsletters and major events for technology leaders around the globe. Red Herring provides an insider's access to the global innovation economy, featuring unparalleled insights on the emerging technologies driving the economy. More information about Red Herring is available on the Internet at www.redherring.com.

    Anam Alpenia
    Red Herring, Inc.
    Phone: 650-428-2900
    Email: aalpenia@redherring.com


'/>"/>
SOURCE Origin BioMed Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
2. Covance Decides to Pursue Its Original Preclinical Strategy in China
3. Brewing better beer: Scientists determine the genomic origins of lager yeasts
4. San Diegos Original Biotech Company Celebrates 30th Anniversary With Reunion
5. Experts prove the geochemical origin of part of the CO2 emissions in semiarid climates
6. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology
7. Three Expert Opinion Journals now Publishing Original Research
8. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics Tissue of Origin Test Designed to Aid in Determination of a Tumors Origin
10. BioMed Realty Trust Extends Leases With Vertex Pharmaceuticals Through 2015
11. Bavarian Nordics Case Against Oxford BioMedica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... today announced the launch of the Supplyframe Design Lab . Located in ... to explore the future of how hardware projects are designed, built and brought ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... , June 2, 2016 The ... has awarded the 44 million US Dollar project, for ... Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... leader in the production and implementation of Identity Management Solutions. ... January, however Decatur was selected for ...
(Date:5/24/2016)... facilitates superior patient care by providing unparalleled technology to leaders of the medical imaging ... product recently added to the range of products distributed by Ampronix. Photo ... ... ... News ...
Breaking Biology News(10 mins):